Edwards’ JenaValve acquisition nixed as FTC injunction approved by court
Edwards Lifesciences has announced that the US District Court for the District of Columbia has approved an injunction motion issued by US Federal Trade Commission (FTC), putting the brakes on the medtech giant’s plans to acquire JenaValve. Edwards will no longer proceed with the acquisition of JenaValve, maker of a transcatheter aortic valve replacement system … Read more